The EC Horizon2020 project STriTuVaD aims to demonstrate how advanced computer modelling and simulation can be used to reduce the costs of the clinical trials required to test the efficacy of new [...]
TBVI along with global partners Aeras, FIND, TBAlliance and Stop TB Partnership Working Groups signed a statement at the UN High Level Meeting on Tuberculosis. Please read the statement.
26 September the UN General Assembly High Level meeting takes place in New York. This High Level meeting is entirely dedicated to tuberculosis: ‘United to end tuberculosis: an urgent global [...]
The University of Geneva has opened a tenure-track position for an assistant professor of human vaccine immunology… endowed by a Charity prior to a permanent University position as [...]
In the effort to eradicate tuberculosis as one of the world’s most deadly diseases, novel TB vaccines will be an important part of the solution. There is a pipeline of new TB vaccines that [...]
Runderweg 6
8219 PK Lelystad
The Netherlands
Email: info@tbvi.eu
Phone: +31 320 277 550
